Enzon Pharmaceuticals, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 53
Rang # Quantité totale PI 25 901
Note d'activité PI 0/5.0    0
Rang # Activité PI 1 659 906
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

1 0
0 1
51 0
0
 
Dernier brevet 2016 - Lna antisense oligonucleotides f...
Premier brevet 1992 - Human mannose-binding protein
Dernière marque 2007 - CUSTOMIZED LINKER TECHNOLOGY
Première marque 2007 - CUSTOMIZED LINKER TECHNOLOGY

Industrie (Classification de Nice)

Derniers inventions, produits et services

2013 Invention Lna antisense oligonucleotides for the modulation of myc expression. The disclosure relates to ol...
2012 Invention Rna antagonist compounds for the modulation of her3. The invention relates to oligomer compounds...
2011 Invention Methods of treating cancers with her3 and pik3ca antisense oligonucleotides. One aspect of the in...
Invention Compositions and methods for treating androgen receptor dependent disorders including cancers. Th...
Invention Compounds for the modulation of beta-catenin expression. The invention relates to oligomer compo...
Invention Polymeric conjugates of adenine nucleoside analogs. The present invention relates to polymeric co...
2010 Invention Polymeric conjugates of aromatic amine containing compounds including releasable urea linker. The...
Invention Rna antagonists targeting hsp27 combination therapy. The present invention relates to antisense o...
Invention Compounds for the modulation of beta-catenin expression. The invention relates to oligomer compou...
Invention Methods of treating her2 positive cancer with her2 receptor antagonist in combination with multi-...
Invention Oligomeric compounds for the modulation of survivin expression. Oligonucleotides directed against...
Invention Methods for inhibiting angiogenesis with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamp...
Invention Methods of treating cancers with her3 antisense oligonucleotides. One aspect of the invention pr...
Invention Methods of treating cancers with her3 antisense oligonucleotides. One aspect of the invention pro...
Invention Short rna antagonist compounds for the modulation of hif-1alpha. The present invention relates t...
Invention Rna antagonists targeting gli2 for the treatment of leukemia. The present invention relates to ol...
2009 Invention Releasable conjugates for nucleic acids delivery systems. The present invention is directed to nu...
Invention Releasable cationic lipids for nucleic acids delivery systems. The present invention is directed ...
Invention Releasable fusogenic lipids for nucleic acids delivery systems. The present invention relates to ...
Invention Releasable polymeric lipids for nucleic acids delivery system. The present invention relates to p...
Invention Posaconazole polymer conjugates and methods of treatment using posaconazole and polymer conjugate...
Invention Erbb-3 (her3)-selective combination therapy. The invention relates to pharmaceutical composition...
Invention Erbb-3 (her3)-selective combination therapy. The invention relates to pharmaceutical compositions...
Invention Treatment of neuroblastoma with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin....
Invention Method of treating ras associated cancer. New methods of treating Ras associated cancer, and espe...
Invention Method of treating ras associated cancer. New methods of treating Ras associated cancer, and esp...
Invention Branched cationic lipids for nucleic acids delivery system. The present invention is directed to ...
Invention Nanoparticle compositions for nucleic acids delivery system. The present invention is directed to...
Invention Rna antagonists targeting gli2. The present invention relates to oligomer compounds (oligomers), ...
Invention Rna antagonists targeting hsp27. The present invention relates to oligomer compounds (oligomers),...
Invention Polymeric systems containing intracellular releasable disulfide linker for the delivery of oligon...
2008 Invention Rna antagonist compounds for the modulation of pik3ca expression. The invention relates to oligom...
Invention Rna antagonist compounds for the modulation of pik3ca expression. The present invention relates t...
Invention Lna antagonists targeting the androgen receptor. The present invention relates to oligomer compou...
Invention Prodrugs of vancomycin with hydrolysis resistant polymer linkages. Vancomycin-polymer conjugates...
Invention Lna oligonucleotides and the treatment of cancer. xc-3′, wherein capital letters designate an LNA...
Invention Short rna antagonist compounds for the modulation of hif1alpha. The present invention relates to ...
Invention Polymeric drug delivery system containing a multi-substituted aromatic moiety. The present invent...
Invention Polymeric drug delivery systems containing an aromatic allylic acid. The present invention provid...
Invention Rna antagonist compounds for the modulation of her3. The invention relates to oligomer compounds ...
2007 Invention Polymeric linkers containing pyridyl disulfide moieties. The present invention provides polymeric...
Invention Indenoisoquinoline-releasable polymer conjugates. The present invention provides releasably-link...
P/S Pharmaceutical research and development including treatment of biologically active materials such...